Sponsored Sites
-
Risk Adjustment Compliance
RAAPID
RAAPID develops AI-powered risk adjustment solutions for healthcare payers, providers, and supporting organizations. The company's HITRUST-certified platform uses Neuro-Symbolic AI to identify chronic conditions, determine HCC codes, and provide explainable documentation for complete audit defense. Backed by M12 (Microsoft's venture fund), RAAPID serves organizations participating in Medicare Advantage, ACA, Medicare ACO, and Medicaid programs with both retrospective and prospective risk capture capabilities. Founded by healthcare technology veterans with over 20 years of experience, RAAPID is headquartered in Louisville, Kentucky.
-
Specialty Drug Management
Optum Specialty Fusion
At Optum, we’re evolving health care so everyone can have the opportunity to live their healthiest life. It’s why we put your unique needs at the heart of everything we do, making it easy and affordable to manage health and well-being. Together, for better health.
-
Revenue Cycle Management
Greenway Health
Improving healthcare through innovation is at the heart of Greenway Health’s work. We provide electronic health records (EHR), practice management, and revenue cycle management solutions that help practices in multiple specialties grow profitably, remain compliant, work more efficiently, and improve patient outcomes.
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
Shadow AI prevalent, as 72% of health orgs deploy without IT approval
Security gaps, including shadow AI deployments, may hamper the use of agentic AI in healthcare despite leaders' confidence in the technology's transformative potential.
-
High healthcare costs force chronically ill patients to skip care, meds
Around half of people with one or more chronic illnesses have skipped or delayed care in the past year, and for a third of them, it was due to high healthcare costs.
-
ARPA-H selects 6 teams for agentic cardiovascular AI program
ARPA-H awarded six contracts to develop autonomous AI agents that can adjust cardiac care plans without human cardiologist oversight as part of its ADVOCATE program.
-
Less than 1% of FDA-cleared AI devices tested for clinical benefits
A recent study revealed that only three of 1,300+ FDA-cleared AI medical devices were evaluated for patient outcomes, exposing gaps in clinical evidence requirements.
-
OpenEvidence launches 4 medical AI models
One of the company's latest models, Darwin, outperformed some of its top competitors by receiving a perfect score on the MedQA benchmark.
-
Medical groups continue to diverge from CDC on fall vaccine schedule
AAFP, AAP and peer groups' vaccine recommendations remain consistent with previous years, but they now diverge from the CDC's advisories calling for shared decision-making before annual COVID vaccination.
Features
-
Inside Hackensack Meridian's first-in-nation Joint Commission AI certification
Following Hackensack Meridian Health achieving Joint Commission's inaugural certification for AI use, its chief digital and information officer discusses what went into getting the honor.
-
As AI tools multiply, health systems are centralizing AI management
Implementations of a centralized platform at Inova Health and Mount Sinai Health System show how unifying AI management can support ongoing AI implementation and governance efforts.
-
From 100 hours to 10: Tech streamlines cancer data collection, insights
Cancer center leaders discuss how joining ConcertAI's CancerLinQ network cut QOPI data abstraction time, while enabling data insights and benchmarking.
-
3 considerations for health systems adopting AI chatbots
As health systems consider adopting their own AI chatbots, they must assess how the tool will fit into the market -- and their end-users' workflows.












